menu
    • menu
    [{"orgOrder":0,"company":"University of Hohenheim","sponsor":"University Hospital T\u00fcbingen | Quercegen Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"GERMANY","productType":"Plant Extract\/Herbal","year":"2012","type":"Inapplicable","leadProduct":"Quercetin","moa":"Acetyl-CoA:lyso-PAF acetyltransferase (PCAT)","graph1":"Oncology","graph2":"Undisclosed","graph3":"University of Hohenheim","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Hohenheim \/ University Hospital T\u00fcbingen | Quercegen Pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"University of Hohenheim \/ University Hospital T\u00fcbingen | Quercegen Pharmaceuticals"},{"orgOrder":0,"company":"University of Michigan","sponsor":"National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2012","type":"Inapplicable","leadProduct":"Quercetin","moa":"Acetyl-CoA:lyso-PAF acetyltransferase (PCAT)","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase I","graph3":"University of Michigan","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Michigan \/ National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health","highestDevelopmentStatusID":"6","companyTruncated":"University of Michigan \/ National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health"},{"orgOrder":0,"company":"University of New Mexico","sponsor":"Gatorade Sports and Science Institute | Quercegen Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2010","type":"Inapplicable","leadProduct":"Quercetin","moa":"Acetyl-CoA:lyso-PAF acetyltransferase (PCAT)","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"University of New Mexico","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of New Mexico \/ Gatorade Sports and Science Institute | Quercegen Pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"University of New Mexico \/ Gatorade Sports and Science Institute | Quercegen Pharmaceuticals"},{"orgOrder":0,"company":"Temple University","sponsor":"National Center for Complementary and Integrative Health | Quercegen Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Quercetin","moa":"Acetyl-CoA:lyso-PAF acetyltransferase (PCAT)","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase II","graph3":"Temple University","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Temple University \/ National Center for Complementary and Integrative Health | Quercegen Pharmaceuticals","highestDevelopmentStatusID":"8","companyTruncated":"Temple University \/ National Center for Complementary and Integrative Health | Quercegen Pharmaceuticals"},{"orgOrder":0,"company":"Temple University","sponsor":"National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2019","type":"Inapplicable","leadProduct":"Quercetin","moa":"Acetyl-CoA:lyso-PAF acetyltransferase (PCAT)","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase II","graph3":"Temple University","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Temple University \/ National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health","highestDevelopmentStatusID":"8","companyTruncated":"Temple University \/ National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health"}]

    Find Clinical Drug Pipeline Developments & Deals for NCGC00025016-03

    Menu

    NCGC00025016-03

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Temple University

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            Temple University

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Study Phase : Phase II

                            Sponsor : National Center for Complementary and Integrative Health | Quercegen Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Biological Effects of Quercetin in COPD Phase II

                            Details : Quercetin is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            August 21, 2023

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Highest Development Status : Phase II

                            Sponsor : National Center for Complementary and Integrative Health | Quercegen Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Temple University

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            Temple University

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Study Phase : Phase I/ Phase II

                            Sponsor : National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Biological Effects of Quercetin in COPD

                            Details : Quercetin is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            June 18, 2019

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Highest Development Status : Phase I/ Phase II

                            Sponsor : National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            University of Michigan

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            University of Michigan

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Study Phase : Phase I

                            Sponsor : National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)

                            Details : Quercetin is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            October 16, 2012

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Highest Development Status : Phase I

                            Sponsor : National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            University of Hohenheim

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            University of Hohenheim

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : University Hospital Tübingen | Quercegen Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Prostate Cancer Prevention Trial With Quercetin and Genistein

                            Details : Quercetin is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Prostatic Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            February 24, 2012

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : University Hospital Tübingen | Quercegen Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            University of New Mexico

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            University of New Mexico

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Gatorade Sports and Science Institute | Quercegen Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Combined Exercise, Heat, and Quercetin Supplementation on Whole Body Stress Response

                            Details : Quercetin is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            July 23, 2010

                            Lead Product(s) : Quercetin

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Gatorade Sports and Science Institute | Quercegen Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth